Townsville Eye Care Education Seminar
Date: 24/03/2019
Venue: The Ville Resort - Casino Sir Leslie Thiess Drive Townsville, QLD, 4810
Provider: Townsville Eye Care
Contact: Donna Chen, [E] donna.chen@townsvilleeyecare.com.au, [P] (07) 4775 6686
Learning Objectives
- Glaucoma Identify important clinical signs requiring action in glaucoma patients
- Glaucoma Identify the new glaucoma treatments and their role in optimising glaucoma treatment
- Glaucoma Consolidate knowledge on anti-glaucoma medications and develop confidence in prescribing
- Technological advances and macular pathology Recognise the impact of technology on identifying and classifying macular pathology
- Technological advances and macular pathology Understand treatment rationale and risks behind injectable therapies
- Technological advances and macular pathology Develop an understanding of the spectrum of macular pathology
- Technological advances and macular pathology Identify common differentials for dry and wet AMD
- Degenerative lesions of the peripheral retina Correctly identify the most common degenerative lesions of the peripheral retina
- Degenerative lesions of the peripheral retina Recognise the frequency of asymptomatic findings and likelihood of management
- Degenerative lesions of the peripheral retina Understand the biomechanics of the eye and its clinical relevance
- Complex cataracts and secondary IOLs Consolidate knowledge on cataract surgery/primary IOLs (and impact on ocular structures)
- Complex cataracts and secondary IOLs Recognise that there are different surgical approaches for complex cataracts
- Complex cataracts and secondary IOLs Identify concerns that may indicate an IOL exchange or secondary IOL
- Diabetic retinopathy Understand the classification of diabetic eye disease
- Diabetic retinopathy Understand the role of laser in the anti-VEGF era
- Diabetic retinopathy Understand the role of medical treatment (i.e. Lipitor)
- Epiretinal membranes and macular holes Recognise the aetiologies of ERMs and MHs
- Epiretinal membranes and macular holes Understand the factors affecting urgency of ERMs and MHs
- Epiretinal membranes and macular holes Develop an understanding of what is involved in retinal surgery
Max points awarded: 18.00
Session Information
| Name |
|---|
| Glaucoma |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name |
|---|
| Diabetic Retinopathy |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name |
|---|
| Technological advances and macular pathology |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 4.50 |
| Name |
|---|
| Degenerative lesions of the peripheral retina |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
| Name |
|---|
| Complex cataracts and secondary IOLs |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name |
|---|
| Epiretinal membranes and macular holes |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| Glaucoma | Face to Face with Assessment | Yes | No | 3.00 |
| Diabetic Retinopathy | Face to Face with Assessment | No | No | 3.00 |
| Technological advances and macular pathology | Face to Face with Assessment | No | No | 3.00 |
| Eyelid and Epiphora | Face to Face with Assessment | No | No | 3.00 |
| Complex cataracts and secondary IOLs | Face to Face with Assessment | No | No | 3.00 |
| Epiretinal membranes and macular holes | Face to Face with Assessment | No | No | 3.00 |